Search research articles
Contact Us
Filters
Showing results (71-80 of 140) with videos related to
Page
of 14
Sort By:
The American Journal of Gastroenterology
|
December 16, 2025
Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes
Jonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
The American Journal of Gastroenterology
|
January 9, 2023
Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis
Jiwon Yang, Won-Mook Choi, Ju Hyun Shim, et al.
JAMA Internal Medicine
|
March 17, 2025
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease
Jonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Journal of Hepatocellular Carcinoma
|
July 8, 2024
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, et al.
Gut
|
October 23, 2017
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 28, 2021
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Sun Yoo, Danbi Lee, Ju Hyun Shim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2025
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching
Jonggi Choi, Tushar Kamath, Vy H Nguyen, et al.
Hepatology Communications
|
April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetes
Jonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Clinical and Molecular Hepatology
|
November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate Fibrosis
Jonggi Choi, Daniel Fulop, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulation
Jonggi Choi, Ana Verma, Vy H Nguyen, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 140) with videos related to
Sort By:
Page
of 14
The American Journal of Gastroenterology
|
December 16, 2025
Association of SGLT2 Inhibitors with Reduced Hepatocellular Carcinoma Risk in Patients with Type 2 Diabetes
Jonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
The American Journal of Gastroenterology
|
January 9, 2023
Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis
Jiwon Yang, Won-Mook Choi, Ju Hyun Shim, et al.
JAMA Internal Medicine
|
March 17, 2025
Statin Use and Risk of Hepatocellular Carcinoma and Liver Fibrosis in Chronic Liver Disease
Jonggi Choi, Vy H Nguyen, Eric Przybyszewski, et al.
Journal of Hepatocellular Carcinoma
|
July 8, 2024
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, et al.
Gut
|
October 23, 2017
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 28, 2021
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
Sun Yoo, Danbi Lee, Ju Hyun Shim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 18, 2025
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching
Jonggi Choi, Tushar Kamath, Vy H Nguyen, et al.
Hepatology Communications
|
April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetes
Jonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.
Clinical and Molecular Hepatology
|
November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate Fibrosis
Jonggi Choi, Daniel Fulop, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulation
Jonggi Choi, Ana Verma, Vy H Nguyen, et al.
Page
of 14